Metformin suppresses sonic hedgehog expression in pancreatic cancer cells

Masafumi Nakamura1, Ayako Ogo, Masahiro Yamura

  • 1Department of Digestive Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan. mnakamura@med.kawasaki-m.ac.jp.

Anticancer Research
|April 3, 2014
PubMed
Abstract

Insights

Metformin was found to suppress Sonic hedgehog (Shh) expression in pancreatic cancer cells and other cancer cell lines. This indicates a potential role for metformin in modulating the Hedgehog signaling pathway in cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Metformin is associated with reduced cancer risk.
  • The Hedgehog signaling pathway is crucial in pancreatic cancer development.
  • Understanding metformin's effect on this pathway is important.

Purpose of the Study:

  • To investigate the impact of metformin on Hedgehog signaling factors.
  • To determine if metformin affects Sonic hedgehog (Shh) expression.

Main Methods:

  • BxPC3 human pancreatic cancer cells were treated with metformin.
  • Sonic hedgehog (Shh) mRNA and protein levels were quantified.
  • Experiments were conducted across multiple cancer cell lines.

Main Results:

  • Metformin significantly suppressed Shh mRNA and protein expression in BxPC3 cells.
  • This inhibitory effect of metformin on Shh was confirmed in three additional cancer cell lines.
  • Shh mRNA inhibition by metformin demonstrated a concentration-dependent relationship in two cell lines.

Conclusions:

  • Metformin effectively reduces Sonic hedgehog (Shh) expression.
  • This effect was observed in pancreatic cancer cells and other cancer cell lines.
  • Metformin may influence cancer progression by modulating the Hedgehog pathway.